Calloso-adreno-scrotal agenesis associated with biallelic MAPK-activating death domain protein (MADD) variant: Further phenotypic delineation of MADD deficiency

Am J Med Genet A. 2024 Mar;194(3):e63463. doi: 10.1002/ajmg.a.63463. Epub 2023 Nov 6.

Abstract

MAPK-activating death domain protein (MADD) deficiency is associated with a broad clinical spectrum ranging from mild developmental impairment to fatal multisystem disorder. We report an additional case of severe form with some overlapping and unreported systemic features in a growth-restricted full-term male newborn. The novel findings include corpus callosum agenesis, bilateral adrenal agenesis, scrotal aplasia, and abnormal skin pigmentation. Microscopic changes are only remarkable in thyroid gland that shows decreased, variously sized follicles with absent or non-vacuolated pale colloid. This unique constellation of birth defects is associated with a novel homozygous in-frame MADD gene deletion (NM_003682.4: c.4853_4855delGCT:p.Cys1618del). This case report expands the phenotypic and genetic spectrum of MADD deficiency.

Keywords: MADD; adrenal agenesis; corpus callosum agenesis; scrotal aplasia; skin pigmentation disorder.

Publication types

  • Case Reports

MeSH terms

  • Agenesis of Corpus Callosum*
  • Death Domain
  • Death Domain Receptor Signaling Adaptor Proteins / genetics
  • Guanine Nucleotide Exchange Factors* / genetics
  • Humans
  • Infant, Newborn
  • Male

Substances

  • MADD protein, human
  • Guanine Nucleotide Exchange Factors
  • Death Domain Receptor Signaling Adaptor Proteins